Full Text View
Tabular View
No Study Results Posted
Related Studies
Biliary Atresia Research Consortium (PROBE)
This study is currently recruiting participants.
Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), February 2009
First Received: June 5, 2003   Last Updated: February 9, 2009   History of Changes
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00061828
  Purpose

Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period.

The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.


Condition
Biliary Atresia
Cholestasis

Study Type: Observational
Study Design: Cohort, Prospective
Official Title: A Prospective Database of Infants With Cholestasis

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Samples of blood, urine and liver tissue samples will be collected for research purposes.


Estimated Enrollment: 400
Study Start Date: May 2004
Groups/Cohorts
Biliary Atresia
Infants presenting with cholestasis who are diagnosed with biliary atresia.
Non-Biliary Atresia
Infants presenting with cholestasis without a diagnosis of biliary atresia.

  Eligibility

Ages Eligible for Study:   up to 6 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

This study population will be selected from the patient base of participating speciality care clinics.

Criteria
  • Age less or equal to 180 days at presentation to clinical site.
  • Clinically meaningful cholestasis due to primary hepatobiliary disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00061828

Locations
United States, California
University of California Recruiting
San Francisco, California, United States, 94143
Contact: Philip Rosenthal, MD     415-476-5892     prosenth@peds.ucsf.edu    
Principal Investigator: Philip Rosenthal, MD            
United States, Colorado
The Children's Hospital Recruiting
Denver, Colorado, United States, 80218
Contact: Ronald Sokol, MD     303-861-6669     sokol.ronald@tchden.org    
Principal Investigator: Ronald Sokol, MD            
Sub-Investigator: Cara Mack, MD            
Sub-Investigator: Michael Narkewicz, MD            
United States, Illinois
Children's Memorial Hospital Recruiting
Chicago, Illinois, United States, 60614
Contact: Peter Whitington, MD     773-880-4643     p-whitington@northwestern.edu    
Principal Investigator: Peter Whitington, MD            
United States, Maryland
Johns Hopkins School of Medicine Recruiting
Baltimore, Maryland, United States, 21287
Contact: Kathleen Schwarz, MD     410-955-8769     kschwarz@jhmi.edu    
Principal Investigator: Kathleen Schwarz, MD            
United States, Missouri
Washington University School of Medicine Recruiting
St Louis, Missouri, United States, 63110
Contact: Ross Shepherd, MD     314-454-2337     shepherd_r@kids.wustl.edu    
Sub-Investigator: Robert Heukeroth, MD            
Principal Investigator: Ross Shepherd, MD            
United States, New York
Mount Sinai Medical Center Recruiting
New York City, New York, United States, 10029
Contact: Frederick J Suchy, MD     212-241-6933     frederick.suchy@mssm.edu    
Principal Investigator: Frederick J Suchy, MD            
Sub-Investigator: Nanda Kerkar, MD            
United States, Ohio
Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Jorge Bezerra, MD     513-636-4928     jorge.bezerra@chmcc.org    
Principal Investigator: Jorge Bezerra, MD            
Sub-Investigator: John Bucuvalas, MD            
United States, Pennsylvania
Children's Hospital of Philadelphia Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Barbara Haber, MD     215-590-2985     haber@email.chop.edu    
Principal Investigator: Barbara Haber, MD            
Sub-Investigator: Elizabeth Rand, MD            
Children's Hospital of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Benjamin Shneider, MD     412-692-5412     benjamin.shneider@chp.edu    
Principal Investigator: Benjamin Shneider, MD            
Sub-Investigator: Robert Squires, Jr, MD            
Sub-Investigator: David Perlmutter, MD            
United States, Texas
Texas Children's Hospital/Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: Saul J Karpen, MD     832-824-3754     skarpen@bcm.tmc.edu    
Principal Investigator: Saul J Karpen, MD            
Sponsors and Collaborators
Investigators
Study Chair: Ronald Sokol, MD The Children's Hospital, Denver
Study Director: Patricia Robuck, PhD National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: John Magee, MD University of Michigan Medical Center, Ann Arbor
  More Information

Additional Information:
No publications provided

Responsible Party: University of Michigan ( Dr. John Magee, Principal Investigator )
Study ID Numbers: BARC, U01-DK62456-01
Study First Received: June 5, 2003
Last Updated: February 9, 2009
ClinicalTrials.gov Identifier: NCT00061828     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Digestive System Abnormalities
Digestive System Diseases
Bile Duct Diseases
Cholestasis
Biliary Tract Diseases
Congenital Abnormalities
Biliary Atresia

Additional relevant MeSH terms:
Digestive System Abnormalities
Digestive System Diseases
Bile Duct Diseases
Cholestasis
Biliary Tract Diseases
Congenital Abnormalities
Biliary Atresia

ClinicalTrials.gov processed this record on July 02, 2009